Search

Your search keyword '"Widhalm, G."' showing total 464 results

Search Constraints

Start Over You searched for: Author "Widhalm, G." Remove constraint Author: "Widhalm, G."
464 results on '"Widhalm, G."'

Search Results

1. Preoperative brain tumor imaging: models and software for segmentation and standardized reporting

2. Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

10. HeartMate 3 Snoopy: Non-invasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers

11. Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

13. P11.18.A Localizing value of EEG recordings in patients with glioblastoma

14. OS03.5.A Characterization of the inflammatory tumor microenvironment composition in solid cancer patients with brain metastases after progression to immune checkpoint inhibitor therapy

15. P11.37.B When to resect or biopsy for patients with supratentorial glioblastoma: a multivariable prediction model

17. P10.15.B Next generation drug screening platform: generation of patient-derived cells forex vivo drug response studies of gliomas

18. P13.04.B Dissecting high-grade glioma immune infiltration in samples from fluorescence-guided surgery: digital pathology with automated image analysis

20. OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial

23. 307P Incidence of neurological symptoms in brain metastases from breast cancer and its impact on prognosis: An analysis of 968 patients with brain metastases

24. P11.55.B Postoperative MRI is able to detect an unexpected residual tumor after surgery of brain metastases: experience from 5 specialized centers

25. 286MO Radiomics-based prediction of lymphocyte infiltration in IDH-wildtype glioblastoma

26. P07.04.B Heme biosynthesis factors and 5-ALA induced fluorescence: analysis of mRNA and protein expression in fluorescing and non-fluorescing gliomas

27. P11.44.A The impact of heme biosynthesis regulation on glioma aggressiveness: correlations with most recent diagnostic molecular markers

29. P11.27.B Whole genome DNA methylation as predictive biomarker in CNS WHO grade 2 and 3 oligodendroglioma patients receiving early postoperative treatment

32. 165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial

39. P14.03 Shifting trends and entity-specific aspects in patients with brain metastasis: real-life analysis from 6031 individuals over an observation period of 30 years

40. 280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial

41. P14.14 Adjuvant treatment versus initial observation in newly diagnosed WHO grade II and grade III oligodendroglioma: real-life data from two academic, tertiary care centers in Austria

45. MicroRNAs as potential 'tissue sensitisers' for the augmentation of glioblastoma immunotherapy

46. The value of visible 5-ALA induced PpIX fluorescence during surgery for spinal ependymomas

47. High interobserver agreement in the semiquantitative classification of 5-ALA fluorescence levels in newly diagnosed glioblastomas

Catalog

Books, media, physical & digital resources